MedPath

Controlled comparative study for the efficacy between famotidine and omeprazole on prevention of delayed bleeding from ulcer after ESD for early gastric cancer

Not Applicable
Conditions
early gastric cancer
Registration Number
JPRN-UMIN000001215
Lead Sponsor
Hyogo College of Medicine Upper gastroenterology Department of internal medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

1. patients with severe liver, renal and cardiopulumonary diseases. 2. patients who took medicines described below within one week before the first day of the study; H2RA, PPI 3. patients who had underwent eradication therapy for H.pylori within 6 months before the first day of the study 4. patients who are pregnancy, in breast-feeding or who wish pregnancy during the study period. 5. patients who are regarded in-eligible by the doctor who participates in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath